Cwm, LLC Capricor Therapeutics, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 427 shares of CAPR stock, worth $6,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares

427

Holding current value

$6,349

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 08, 2024	BUY	$3.56 - $15.21 $1,520 - $6,494	427 New	427 $6,000
Q1 2020 Apr 28, 2020	BUY	$0.94 - $2.02 $339 - $729	361 New	361 $0

Others Institutions Holding CAPR

# of Institutions

Shares Held

8.13M

Call Options Held

1.78M

Put Options Held

1.4M

Black Rock Inc. New York, NY

1.63M
Shares

$24.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.58M
Shares

$23.4 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

638K
Shares

$9.49 Million
0.0% of portfolio
State Street Corp Boston, MA

512K
Shares

$7.62 Million
0.0% of portfolio
Superstring Capital Management LP New York, NY

337K
Shares

$5.02 Million
4.49% of portfolio

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $362M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account